Posted 10 September 2021
Eyetelligence is setting a new benchmark in patient care by enhancing accuracy and efficiency in clinical decision making. Its advanced AI and automation uses the eye as a gateway to detect and prevent ocular, cardiovascular and microvascular diseases in their earliest stages.
In preparation for an IPO in 2022, the company seeks an experienced Independent Director to contribute to the international development of its AI-based products and services.
You are a seasoned governance professional with expertise gained in navigating ASX compliance requirements. Your experience in building SaaS businesses is underpinned by a passion for clinical excellence and a global perspective.
Please view the position profile here and send a brief governance CV by 5pm Monday 4 October to email@example.com, or ring Jeremy Wurm on 0419 529 525 or Lesley Lightfoot on 0458 543 485, in confidence.